Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Credit agrmnt [a] RE purchase Appointed director CC transcript Inv. presentation
|
SANFILIPPO JOHN B & SON INC (JBSS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/21/2021 |
GN
| John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal 2021 Operating Results Conference Call |
01/20/2021 |
GN
| John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal 2021 Operating Results Conference Call |
10/19/2020 |
GN
| John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal 2021 Operating Results Conference Call |
08/12/2020 |
GN
| John B. Sanfilippo & Son, Inc. 4th Quarter and Fiscal 2020 Year-End Operating Results Conference Call |
04/22/2020 |
GN
| John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal 2020 Operating Results Conference Call |
10/22/2019 |
GN
| John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal 2020 Operating Results Conference Call |
08/15/2019 |
GN
| John B. Sanfilippo & Son, Inc. 4th Quarter and Fiscal 2019 Year-End Operating Results Conference Call |
04/25/2019 |
GN
| John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal 2019 Operating Results Conference Call |
02/13/2019 |
GN
| Recent Analysis Shows General Mills, Paycom Software, Invitae, Jagged Peak Energy, John B. Sanfilippo & Son, and Intrepid Potash Market Influences — Renewed Outlook, Key Drivers of Growth |
01/24/2019 |
GN
| John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal 2019 Operating Results Conference Call |
11/08/2018 |
GN
| New Research Coverage Highlights John B. Sanfilippo & Son, Axcelis Technologies, Cogent Communications, Star Bulk Carriers, Agios Pharmaceuticals, and MDC Partners — Consolidated Revenues, Company Growth, and Expectations for 2018 |
10/24/2018 |
GN
| John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal 2019 Operating Results Conference Call |
10/16/2018 |
GN
| New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular Templates, and Aevi Genomic Medicine — Consolidated Revenues, Company Growth, and Expectations for 2018 |
08/16/2018 |
GN
| John B. Sanfilippo & Son, Inc. 4th Quarter and Fiscal 2018 Year-End Operating Results Conference Call |
08/16/2018 |
GN
| Report: Exploring Fundamental Drivers Behind LGI Homes, Key Energy Services, FS, On Deck Capital, John B. Sanfilippo & Son, and Blue Bird — New Horizons, Emerging Trends, and Upcoming Developments |
05/25/2018 |
GN
| Recent Analysis Shows Credit Acceptance, Hanmi Financial, Upland Software, John B. Sanfilippo & Son, Green, and Lakeland Financial Market Influences — Renewed Outlook, Key Drivers of Growth |
05/03/2018 |
BW
| John B. Sanfilippo & Son, Inc. Third Quarter Diluted EPS Increased by 35.9% to a third quarter record of $0.75 per share |
04/27/2018 |
GN
| John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal 2018 Operating Results Conference Call |
04/03/2018 |
GN
| New Research: Key Drivers of Growth for UNITIL, EMCORE, Thermon Group, John B. Sanfilippo & Son, Hyster-Yale Materials Handling, and Valero Energy Partners LP — Factors of Influence, Major Initiatives and Sustained Production |
02/05/2018 |
BW
| John B. Sanfilippo & Son, Inc. Net Sales Grew by 3.9% on Strong Sales Volume Performance in the Consumer Distribution Channel |
02/02/2018 |
GN
| Report: Exploring Fundamental Drivers Behind John B. Sanfilippo & Son, Spero Therapeutics, Live Oak Bancshares, Medtronic, Automatic Data Processing, and Enphase Energy — New Horizons, Emerging Trends, and Upcoming Developments |
01/29/2018 |
GN
| John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal 2018 Operating Results Conference Call |
10/24/2017 |
GN
| John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal 2018 Operating Results Conference Call |
08/17/2017 |
GN
| John B. Sanfilippo & Son, Inc. 4th Quarter and Fiscal 2017 Year-End Operating Results Conference Call |
05/12/2017 |
BW
| John B. Sanfilippo & Son, Inc. to Present at the East Coast IDEAS Investor Conference on May 17th & 18th in Boston |
|
|